Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

102 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Funds Reimbursement of High-Cost Drugs in Gastrointestinal Oncology: An Italian Real Practice 1 Year Experience at the National Cancer Institute of Naples.
Capozzi M, De Divitiis C, Ottaiano A, Teresa T, Capuozzo M, Maiolino P, Botti G, Tafuto S, Avallone A; Abdominal Oncology Group. Capozzi M, et al. Among authors: tafuto s. Front Public Health. 2018 Oct 12;6:291. doi: 10.3389/fpubh.2018.00291. eCollection 2018. Front Public Health. 2018. PMID: 30370266 Free PMC article.
Phase I-II trial of gemcitabine-based first-line chemotherapies for small cell lung cancer in elderly patients with performance status 0-2: the G-STEP trial.
Gridelli C, Gallo C, Morabito A, Iaffaioli RV, Favaretto A, Isa L, Barbera S, Gamucci T, Ceribelli A, Filipazzi V, Maione P, Rossi A, Barletta E, Signoriello S, De Maio E, Piccirillo MC, Di Maio M, Rocco G, Vecchione A, Perrone F; G-STEP Investigators. Gridelli C, et al. J Thorac Oncol. 2012 Jan;7(1):233-42. doi: 10.1097/JTO.0b013e318233d6c2. J Thorac Oncol. 2012. PMID: 22031232 Free article. Clinical Trial.
Gastrointestinal non colorectal cancer. Do elderly patients need a specific management?
Silvestro L, Nasti G, Ottaiano A, Montano M, Casaretti R, Avallone A, Berretta M, Romano C, Cassata A, Tafuto S, Iaffaioli RV. Silvestro L, et al. Among authors: tafuto s. Anticancer Agents Med Chem. 2013 Nov;13(9):1364-70. doi: 10.2174/18715206113136660356. Anticancer Agents Med Chem. 2013. PMID: 24102272 Review.
A clinical and radiological objective tumor response with somatostatin analogs (SSA) in well-differentiated neuroendocrine metastatic tumor of the ileum: a case report.
De Divitiis C, von Arx C, Carbone R, Tatangelo F, Di Girolamo E, Romano GM, Ottaiano A, de Lutio di Castelguidone E, Iaffaioli RV, Tafuto S. De Divitiis C, et al. Among authors: tafuto s. Onco Targets Ther. 2015 Mar 31;8:669-75. doi: 10.2147/OTT.S71025. eCollection 2015. Onco Targets Ther. 2015. PMID: 25878507 Free PMC article.
Everolimus and pancreatic neuroendocrine tumors (PNETs): Activity, resistance and how to overcome it.
Capozzi M, Caterina I, De Divitiis C, von Arx C, Maiolino P, Tatangelo F, Cavalcanti E, Di Girolamo E, Iaffaioli RV, Scala S, Tafuto S; ENETS Center of Excellence Multidisciplinary Group for Neuroendocrine Tumors in Naples (Italy). Capozzi M, et al. Among authors: tafuto s. Int J Surg. 2015 Sep;21 Suppl 1:S89-94. doi: 10.1016/j.ijsu.2015.06.064. Epub 2015 Jun 27. Int J Surg. 2015. PMID: 26123382 Free article. Review.
Electrochemotherapy as a new approach on pancreatic cancer and on liver metastases.
Tafuto S, von Arx C, De Divitiis C, Maura CT, Palaia R, Albino V, Fusco R, Membrini M, Petrillo A, Granata V, Izzo F; ENETS Center of Excellence Multidisciplinary Group for Neuroendocrine Tumors in Naples (Italy). Tafuto S, et al. Int J Surg. 2015 Sep;21 Suppl 1:S78-82. doi: 10.1016/j.ijsu.2015.04.095. Epub 2015 Jun 27. Int J Surg. 2015. PMID: 26123385 Free article. Review.
Diabetes and Body Mass Index Are Associated with Neuropathy and Prognosis in Colon Cancer Patients Treated with Capecitabine and Oxaliplatin Adjuvant Chemotherapy.
Ottaiano A, Nappi A, Tafuto S, Nasti G, De Divitiis C, Romano C, Cassata A, Casaretti R, Silvestro L, Avallone A, Capuozzo M, Capozzi M, Maiolino P, Quagliariello V, Scala S, Iaffaioli VR. Ottaiano A, et al. Among authors: tafuto s. Oncology. 2016;90(1):36-42. doi: 10.1159/000442527. Epub 2016 Jan 6. Oncology. 2016. PMID: 26731722
Metronomic temozolomide as second line treatment for metastatic poorly differentiated pancreatic neuroendocrine carcinoma.
De Divitiis C, von Arx C, Grimaldi AM, Cicala D, Tatangelo F, Arcella A, Romano GM, Simeone E, Iaffaioli RV, Ascierto PA, Tafuto S; European Neuroendocrine Tumor Society (ENETS) Center of Excellence-Multidisciplinary Group for Neuroendocrine Tumors in Naples (Italy). De Divitiis C, et al. Among authors: tafuto s. J Transl Med. 2016 May 3;14(1):113. doi: 10.1186/s12967-016-0857-1. J Transl Med. 2016. PMID: 27142424 Free PMC article.
Antiangiogenic Therapy in Pancreatic Neuroendocrine Tumors.
Capozzi M, VON Arx C, DE Divitiis C, Ottaiano A, Tatangelo F, Romano GM, Tafuto S; (On behalf of ENETS Center of Excellence Multidisciplinary Group for Neuroendocrine Tumors in Naples, Italy). Capozzi M, et al. Among authors: tafuto s. Anticancer Res. 2016 Oct;36(10):5025-5030. doi: 10.21873/anticanres.11071. Anticancer Res. 2016. PMID: 27798861 Review.
102 results